Novel automated AIMLAM for diagnosis of Mycobacterium tuberculosis

Papers of special note have been highlighted as: • of interest

References

• 1. Bhargava A. Bhargava M. tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key. J. Clin. Tuberc. Mycobact. Dis. 19, 100155 (2020).
  MedlineGoogle Scholar
• 2. Lin C-H, Lin C-J, Kuo Y-W et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect. Dis. 14, 5 (2014).
  MedlineGoogle Scholar
• 3. MacNeil A. Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets – 2017. MMWR Morb. Mortal. Wkly Rep. [Internet] 68 (2019) [cited 2023 May 22]; Available from: https://www.cdc.gov/mmwr/volumes/68/wr/mm6811a3.htm
  Google Scholar
• 4. Abo-Kadoum MA, Dai Y, Asaad M et al. Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis. Microb. Drug Resist. [Internet] (2020) [cited 2021 Jan 17]; Available from: https://www.liebertpub.com/doi/abs/10.1089/mdr.2020.0179
  Google Scholar
• 5. Aktas E, Durmaz R, Yang D et al. Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Microb. Drug Resist. 11, 94–99 (2005).
  Medline CASGoogle Scholar
• 6. Al-Mutairi NM, Ahmad S, Mokaddas E et al. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. BMC Infect. Dis. 19, 3 (2019).
  MedlineGoogle Scholar
• 7. Brandis G, Hughes D. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. J. Antimicrob. Chemother. 68, 2493–2497 (2013).
  Medline CASGoogle Scholar
• 8. Malenfant JH, Brewer TF. Rifampicin mono-resistant tuberculosis-a review of an uncommon but growing challenge for global tuberculosis control. Open Forum Infect. Dis. 8, ofab018 (2021).
  MedlineGoogle Scholar
• 9. Pienaar E, Linderman JJ, Kirschner DE. Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas. PLoS One 13, e0196322 (2018).
  MedlineGoogle Scholar
• 10. Huang F, Cheng S, Du X et al. Electronic recording and reporting system for tuberculosis in China: experience and opportunities. J. Am. Med. Inform Assoc. 21, 938–941 (2014).
  MedlineGoogle Scholar
• 11. Ayles H, Muyoyeta M, Du Toit E et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet Lond. Engl. 382, 1183–1194 (2013).
  MedlineGoogle Scholar
• 12. Fox GJ, Nhung NV, Sy DN et al. Household-contact investigation for detection of tuberculosis in Vietnam. N. Engl. J. Med. 378, 221–229 (2018). • Highlighted the effectiveness of household-contact investigation for detecting tuberculosis.
  MedlineGoogle Scholar
• 13. Shah NS, Yuen CM, Heo M et al. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin. Infect. Dis. Off. Publ. Infect Dis. Soc. Am. 58, 381–391 (2014).
  MedlineGoogle Scholar
• 14. Hopewell PC, Fair E, Miller C. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-Income countries [Internet]. World Health Organization, Geneva, Switzerland (2012) [cited 2023 Jun 1]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK179062/
  Google Scholar
• 15. Systematic Screening for Active Tuberculosis: Principles and Recommendations [Internet]. World Health Organization, Geneva (2013) [cited 2023 Jun 1]. Available from: http://site.ebrary.com/id/10931306
  Google Scholar
• 16. Reid MJA, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect. Dis. 9, 173–184 (2009).
  MedlineGoogle Scholar
• 17. Hillemann D, Rüsch-Gerdes S, Boehme C et al. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J. Clin. Microbiol. 49, 1202–1205 (2011).
  Medline CASGoogle Scholar
• 18. MacLean E, Kohli M, Weber SF et al. Advances in molecular diagnosis of tuberculosis. J. Clin. Microbiol. 58, e01582–19 (2020).
  Medline CASGoogle Scholar
• 19. Nandlal L, Perumal R, Naidoo K. Rapid molecular assays for the diagnosis of drug-resistant tuberculosis. Infect. Drug Resist. 15, 4971–4984 (2022).
  MedlineGoogle Scholar
• 20. Velen K, Podewils LJ, Shah NS et al. Performance of GeneXpert MTB/RIF for diagnosing tuberculosis among symptomatic household contacts of index patients in South Africa. Open Forum Infect. Dis. 8, ofab025 (2021).
  MedlineGoogle Scholar
• 21. Horsburgh CR, Barry CE, Lange C. Treatment of tuberculosis. N. Engl. J. Med. 373, 2149–2160 (2015).
  Medline CASGoogle Scholar
• 22. Ma J, Jiang G, Ma Q et al. Rapid detection of airborne protein from Mycobacterium tuberculosis using a biosensor detection system. Analyst 147, 614–624 (2022).
  Medline CASGoogle Scholar
• 23. Tiberi S, Utjesanovic N, Galvin J et al. Drug resistant TB – latest developments in epidemiology, diagnostics and management. Int. J. Infect. Dis. 124, S20–S25 (2022).
  Medline CASGoogle Scholar
• 24. Trébucq A, Devi S. Widespread use of Xpert(^®) MTB/RIF will most probably reduce the total number of TB cases notified. Int. J. Tuberc. Lung Dis. Off J. Int. Union Tuberc. Lung Dis. 19, 1406 (2015).
  MedlineGoogle Scholar
• 25. Luetkemeyer AF, Kendall MA, Wu X et al. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J. Clin. Microbiol. 52, 1052–1059 (2014).
  MedlineGoogle Scholar
• 26. Strohmeier GR, Fenton MJ. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes Infect. 1, 709–717 (1999). • It explores the roles of lipoarabinomannan in tuberculosis pathogenesis, and significance of this molecule in the disease's development and progression.
  Medline CASGoogle Scholar
• 27. Broger T, Sossen B, du Toit E et al. Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study. Lancet Infect. Dis. 19, 852–861 (2019). • This reference investigated a new lipoarabinomannan point-of-care tuberculosis test and its diagnostic accuracy.
  MedlineGoogle Scholar
• 28. Flores J, Cancino JC, Chavez-Galan L. Lipoarabinomannan as a point-of-care assay for diagnosis of tuberculosis: how far are we to use it? Front. Microbiol. 12, 638047 (2021). • Evaluated the utility of lipoarabinomannan as a point-of-care assay for tuberculosis diagnosis.
  MedlineGoogle Scholar
• 29. Whitelaw AC, Sturm WA. Chapter 18 – Microbiological testing for Mycobacterium tuberculosis. In: Tuberculosis [Internet]. Schaaf HSZumla AIGrange JM et al. (Eds). W.B. Saunders, Edinburgh, 169–178 (2009) [cited 2023 Jun 1]. Available from: https://www.sciencedirect.com/science/article/pii/B9781416039884000184
  Google Scholar
• 30. Bulterys MA, Wagner B, Redard-Jacot M et al. Point-of-care urine LAM tests for tuberculosis diagnosis: a status update. J. Clin. Med. 9, 111 (2019).
  MedlineGoogle Scholar
• 31. Nkereuwem E, Togun T, Gomez MP et al. Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study. Lancet Infect. Dis. 21, 376–384 (2021). • Conducted a cross-sectional analysis to compare the accuracy of lipoarabinomannan urine tests for diagnosing pulmonary tuberculosis in children.
  Medline CASGoogle Scholar
• 32. Choudhary A, Patel D, Honnen W et al. Characterization of the antigenic heterogeneity of lipoarabinomannan, the major surface glycolipid of Mycobacterium tuberculosis, and complexity of antibody specificities toward this antigen. J. Immunol. Baltim. Md. 1950 200, 3053–3066 (2018).
  CASGoogle Scholar
• 33. Mitamura K, Shimizu H, Yamazaki M et al. Clinical evaluation of highly sensitive silver amplification immunochromatography systems for rapid diagnosis of influenza. J. Virol. Methods 194, 123–128 (2013).
  Medline CASGoogle Scholar
• 34. Sigal GB, Pinter A, Lowary TL et al. A novel sensitive immunoassay targeting the 5-methylthio-d-xylofuranose-lipoarabinomannan epitope meets the WHO's performance target for tuberculosis diagnosis. J. Clin. Microbiol. 56, e01338-18 (2018). • A novel and sensitive immunoassay was introduced, targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan epitope.
  MedlineGoogle Scholar
• 35. Tang P, Zhao Z, Liu Y et al. Comparison between chemiluminescence and colloidal gold method in the detection of 2019 novel coronavirus specific antibodies and the value in COVID-19 diagnosis and treatment. Med. J. Wuhan Univ. 41(4), 517–520 (2020). • Compared the detection of 2019 novel coronavirus-specific antibodies using chemiluminescence and colloidal gold methods.
  Google Scholar
• 36. Stefanova P, Taseva M, Georgieva T et al. A modified CTAB method for DNA extraction from soybean and meat products. Biotechnol. Biotechnol. Equip. 27, 3803–3810 (2013).
  CASGoogle Scholar
• 37. Shuaib YA, Khalil EAG, Schaible UE et al. Smear microscopy for diagnosis of pulmonary tuberculosis in Eastern Sudan. Tuberc. Res. Treat. 2018, 8038137–8038137 (2018).
  MedlineGoogle Scholar
• 38. Kafatos G, Verlander N, Gelb D et al. A comparison of public domain software for outbreak investigations: Epi Info and EpiData. Wkly Releases 1997–2007 12, 3111 (2007).
  Google Scholar
• 39. Cudahy P, Shenoi S. Diagnostics for pulmonary tuberculosis. Postgrad. Med. J. 92, 187–193 (2016).
  MedlineGoogle Scholar
• 40. Dong B, He Z, Li Y et al. Improved conventional and new approaches in the diagnosis of tuberculosis. Front. Microbiol. 13, 924410 (2022).
  MedlineGoogle Scholar
• 41. Sari NIP, Mertaniasih NM, Soedarsono et al. Application of serial tests for Mycobacterium tuberculosis detection to active lung tuberculosis cases in Indonesia. BMC Res. Notes 12, 313 (2019).
  MedlineGoogle Scholar
• 42. Gill CM, Dolan L, Piggott LM et al. New developments in tuberculosis diagnosis and treatment. Breathe [Internet] 18 (2022) [cited 2023 Dec 21]; Available from: https://breathe.ersjournals.com/content/18/1/210149
  Google Scholar
• 43. Mechal Y, Benaissa E, El mrimar N et al. Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis. BMC Infect. Dis. 19, 1069 (2019).
  Medline CASGoogle Scholar
• 44. Initial therapy for tuberculosis in the era of multidrug resistance – Recommendations of the Advisory Council for the Elimination of Tuberculosis [Internet]. [cited 2023 Dec 21]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00020964.htm
  Google Scholar
• 45. Maitra A, Kamil TK, Shaik M et al. Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): a report from Euroscicon's international TB Summit 2016. Virulence 8, 1005–1024 (2016).
  MedlineGoogle Scholar
• 46. Fox GJ, Schaaf HS, Mandalakas A et al. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases. Clin. Microbiol. Infect 23, 147–153 (2017).
  Medline CASGoogle Scholar
• 47. Htun YM, Khaing TMM, Yin Y et al. Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study. BMC Health Serv. Res. 18, 878 (2018).
  MedlineGoogle Scholar
• 48. Deng S, Sun Y, Xia H et al. Accuracy of commercial molecular diagnostics for the detection of pulmonary tuberculosis in china: a systematic review. Sci. Rep. 9, 4553 (2019).
  MedlineGoogle Scholar
• 49. Comella-del-Barrio P, Bimba JS, Adelakun R et al. Fujifilm SILVAMP TB-LAM for the diagnosis of tuberculosis in Nigerian adults. J. Clin. Med. 10, 2514 (2021).
  MedlineGoogle Scholar
• 50. Comparative analysis of clinical application value of four different detection methods for infectious diseases. Labeled Immunoass. Clin. Med. 23, 688–690 (2016).
  Google Scholar
• 51. Nagpal S, Chopra GS, Oberoi A et al. Conventional versus molecular methods for diagnosis of tuberculosis in a tertiary care center: a study from Punjab. CHRISMED J. Health Res. 3, 258 (2016).
  Google Scholar
• 52. Allahyartorkaman M, Mirsaeidi M, Hamzehloo G et al. Low diagnostic accuracy of Xpert MTBs/RIF assay for extrapulmonary tuberculosis: a multicenter surveillance. Sci. Rep. 9, 18515 (2019).
  Medline CASGoogle Scholar
• 53. Tang J, Chen H, Chen F. CT and MRI presentation of nasopharyngeal tuberculosis (with a case report). Radiol. Case Rep. 19, 1702–1707 (2024).
  MedlineGoogle Scholar